CPhaMAS: The first pharmacokinetic analysis cloud platform developed by China.

Yun Kuang, Dongsheng Cao, Dan Jiang, Yonghui Zuo, Feng Lu, Jinghan Yuan, Zhen Fang, Yi Zou, Hong Wang, Chengkun Wu, Qi Pei, Guoping Yang
{"title":"CPhaMAS: The first pharmacokinetic analysis cloud platform developed by China.","authors":"Yun Kuang, Dongsheng Cao, Dan Jiang, Yonghui Zuo, Feng Lu, Jinghan Yuan, Zhen Fang, Yi Zou, Hong Wang, Chengkun Wu, Qi Pei, Guoping Yang","doi":"10.11817/j.issn.1672-7347.2024.240118","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Software for pharmacological modeling and statistical analysis is essential for drug development and individualized treatment modeling. This study aims to develop a pharmacokinetic analysis cloud platform that leverages cloud-based benefits, offering a user-friendly interface with a smoother learning curve.</p><p><strong>Methods: </strong>The platform was built using Rails as the framework, developed in Julia language, and employs PostgreSQL 14 database, Redis cache, and Sidekiq for asynchronous task management. Four commonly used modules in clinical pharmacology research were developed: Non-compartmental analysis, bioequivalence/bioavailability analysis, compartment model analysis, and population pharmacokinetics modeling. The platform ensured comprehensive data security and traceability through multiple safeguards, including data encryption, access control, transmission encryption, redundant backups, and log management. The platform underwent basic function, performance, reliability, usability, and scalability testing, along with practical case studies.</p><p><strong>Results: </strong>The CPhaMAS cloud platform successfully implemented the 4 module functionalities. The platform provides a list-based navigation for users, featuring checkbox-style interactions. Through cloud computing, it allows direct online data analysis, saving computer storage and minimizing performance requirements. Modeling and visualization do not require programming knowledge. Basic functionality achieved 100% completion, with an average annual uptime of over 99%. Server response time was between 200 to 500 ms, and average CPU usage was maintained below 30%. In a practical case study, cefotaxime sodium/tazobactam sodium injection (6꞉1 ratio) displayd near-linear pharmacokinetics within a dose range of 1.0 to 4.0 g, with no significant effect of tazobactam on the pharmacokinetic parameters of cefotaxime, validating the platform's usability and reliability.</p><p><strong>Conclusions: </strong>CPhaMAS provides an integrated modeling and statistical tool for educators, researchers, and industrial professionals, enabling non-compartmental analysis, bioequivalence/bioavailability analysis, compartmental model building, and population pharmacokinetic modeling and simulation.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"49 8","pages":"1290-1300"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11628230/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中南大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.11817/j.issn.1672-7347.2024.240118","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Software for pharmacological modeling and statistical analysis is essential for drug development and individualized treatment modeling. This study aims to develop a pharmacokinetic analysis cloud platform that leverages cloud-based benefits, offering a user-friendly interface with a smoother learning curve.

Methods: The platform was built using Rails as the framework, developed in Julia language, and employs PostgreSQL 14 database, Redis cache, and Sidekiq for asynchronous task management. Four commonly used modules in clinical pharmacology research were developed: Non-compartmental analysis, bioequivalence/bioavailability analysis, compartment model analysis, and population pharmacokinetics modeling. The platform ensured comprehensive data security and traceability through multiple safeguards, including data encryption, access control, transmission encryption, redundant backups, and log management. The platform underwent basic function, performance, reliability, usability, and scalability testing, along with practical case studies.

Results: The CPhaMAS cloud platform successfully implemented the 4 module functionalities. The platform provides a list-based navigation for users, featuring checkbox-style interactions. Through cloud computing, it allows direct online data analysis, saving computer storage and minimizing performance requirements. Modeling and visualization do not require programming knowledge. Basic functionality achieved 100% completion, with an average annual uptime of over 99%. Server response time was between 200 to 500 ms, and average CPU usage was maintained below 30%. In a practical case study, cefotaxime sodium/tazobactam sodium injection (6꞉1 ratio) displayd near-linear pharmacokinetics within a dose range of 1.0 to 4.0 g, with no significant effect of tazobactam on the pharmacokinetic parameters of cefotaxime, validating the platform's usability and reliability.

Conclusions: CPhaMAS provides an integrated modeling and statistical tool for educators, researchers, and industrial professionals, enabling non-compartmental analysis, bioequivalence/bioavailability analysis, compartmental model building, and population pharmacokinetic modeling and simulation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CPhaMAS:国内首个药代动力学分析云平台。
目的:药理学建模和统计分析软件对药物开发和个体化治疗建模至关重要。本研究旨在开发一个药代动力学分析云平台,利用基于云的优势,提供用户友好的界面和更流畅的学习曲线。方法:以Rails为框架构建平台,采用Julia语言开发,采用PostgreSQL 14数据库、Redis缓存和Sidekiq进行异步任务管理。开发了临床药理学研究中常用的四个模块:非室室分析、生物等效性/生物利用度分析、室室模型分析和群体药代动力学建模。该平台通过数据加密、访问控制、传输加密、冗余备份和日志管理等多重保障措施,确保了全面的数据安全性和可追溯性。该平台经过了基本功能、性能、可靠性、可用性和可伸缩性测试,以及实际案例研究。结果:CPhaMAS云平台成功实现了4个模块功能。该平台为用户提供了一个基于列表的导航,具有复选框样式的交互。通过云计算,它允许直接在线数据分析,节省计算机存储并最大限度地降低性能要求。建模和可视化不需要编程知识。基本功能100%完成,年平均正常运行时间超过99%。服务器响应时间在200到500 ms之间,平均CPU使用率保持在30%以下。在实际案例研究中,头孢噻肟钠/他唑巴坦钠注射液(6 1比)在1.0 ~ 4.0 g剂量范围内呈近似线性药代动力学,他唑巴坦对头孢噻肟药代动力学参数无显著影响,验证了平台的可用性和可靠性。结论:CPhaMAS为教育工作者、研究人员和工业专业人员提供了一个集成的建模和统计工具,可以进行非区隔分析、生物等效性/生物利用度分析、区隔模型构建以及群体药代动力学建模和模拟。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
中南大学学报(医学版)
中南大学学报(医学版) Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
8237
期刊介绍: Journal of Central South University (Medical Sciences), founded in 1958, is a comprehensive academic journal of medicine and health sponsored by the Ministry of Education and Central South University. The journal has been included in many important databases and authoritative abstract journals at home and abroad, such as the American Medline, Pubmed and its Index Medicus (IM), the Netherlands Medical Abstracts (EM), the American Chemical Abstracts (CA), the WHO Western Pacific Region Medical Index (WPRIM), and the Chinese Science Citation Database (Core Database) (CSCD); it is a statistical source journal of Chinese scientific and technological papers, a Chinese core journal, and a "double-effect" journal of the Chinese Journal Matrix; it is the "2nd, 3rd, and 4th China University Excellent Science and Technology Journal", "2008 China Excellent Science and Technology Journal", "RCCSE China Authoritative Academic Journal (A+)" and Hunan Province's "Top Ten Science and Technology Journals". The purpose of the journal is to reflect the new achievements, new technologies, and new experiences in medical research, medical treatment, and teaching, report new medical trends at home and abroad, promote academic exchanges, improve academic standards, and promote scientific and technological progress.
期刊最新文献
Multidisciplinary integration and fusion based on critical care medicine and immunology: History, current status, and prospects. Pre-assembled nanospheres in mucoadhesive microneedle patch for sustained release of triamcinolone in the treatment of oral submucous fibrosis. Pyroptosis and sepsis-associated acute kidney injury. Regulatory role of the mTOR signaling pathway in autophagy and mesangial proliferation in IgA nephropathy. Research progress in anti-renal fibrosis drugs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1